Euclid Advisors’s Eastman Chemical EMN Stock Holding History

Euclid Advisors’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-27,999	Closed	-$1.9M	–	155
2016 Q2	$1.9M	Buy	27,999 +21,639	+340%	+$1.59M	0.08%	281
2016 Q1	$459K	Buy	+6,360	New	+$417K	0.02%	377
2015 Q3	–	Sell	-56,650	Closed	-$4.63M	–	286
2015 Q2	$4.63M	Buy	+56,650	New	+$4.37M	0.09%	247
2014 Q4	–	Sell	-315,366	Closed	-$25.5M	–	409
2014 Q3	$25.5M	Buy	315,366 +35,590	+13%	+$2.97M	0.18%	118
2014 Q2	$24.4M	Sell	279,776 -81,830	-23%	-$7.11M	0.17%	138
2014 Q1	$31.2M	Buy	361,606 +96,810	+37%	+$7.94M	0.24%	94
2013 Q4	$21.4M	Sell	264,796 -5,520	-2%	-$429K	0.18%	128
2013 Q3	$21.1M	Buy	270,316 +49,717	+23%	+$3.83M	0.21%	109
2013 Q2	$15.4M	Buy	+220,599	New	+$15.4M	0.2%	130

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Euclid Advisors's EMN Position: Q3 2016 in Review

Euclid Advisors sold out of Eastman Chemical (EMN) in Q3 2016, closing a stake of 27,999 shares — an estimated $1.9M sold.

Euclid Advisors first reported a position in EMN in Q2 2013 and held it in 9 quarters. The position peaked at $31.2M in Q1 2014. 564 funds tracked by Wall St. Rank hold EMN as of Q3 2016.

Euclid Advisors reported no remaining Eastman Chemical position as of Q3 2016 after selling out during the quarter.
Euclid Advisors sold 27,999 Eastman Chemical shares in Q3 2016, an estimated $1.9M.
Euclid Advisors first reported a position in Eastman Chemical in Q2 2013 and held it in 9 quarters.
Euclid Advisors's Eastman Chemical position peaked at $31.2M in Q1 2014.
564 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.